English
简体中文
Total: £ 56.28
Published Date: 2026-04-22 | Pages: 123 | Tables: 121 | Pharma & Healthcare
The global Escitalopram Oxalate API market was valued at US$ 78.03 million in 2025 and is anticipated to reach US$ 124 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Escitalopram Oxalate API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy"s, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
This report delivers a comprehensive overview of the global Escitalopram Oxalate API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Escitalopram Oxalate API. The Escitalopram Oxalate API market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Escitalopram Oxalate API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Escitalopram Oxalate API manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
by Application
Depression Drug
Anxiety Drug
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Escitalopram Oxalate API manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Escitalopram Oxalate API sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Escitalopram Oxalate API Market Overview
1.1 Product Definition
1.2 Escitalopram Oxalate API by Type
1.2.1 Global Escitalopram Oxalate API Market Value by Type: 2025 vs 2032
1.2.2 Both USDMF and COS/E-DM
1.2.3 Only USDMF or COS/E-DM
1.3 Escitalopram Oxalate API by Application
1.3.1 Global Escitalopram Oxalate API Market Value by Application: 2025 vs 2032
1.3.2 Depression Drug
1.3.3 Anxiety Drug
1.4 Global Escitalopram Oxalate API Market Size Estimates and Forecasts
1.4.1 Global Escitalopram Oxalate API Revenue 2021–2032
1.4.2 Global Escitalopram Oxalate API Sales 2021–2032
1.4.3 Global Escitalopram Oxalate API Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Escitalopram Oxalate API Market Competition by Manufacturers
2.1 Global Escitalopram Oxalate API Sales Market Share by Manufacturers (2021–2026)
2.2 Global Escitalopram Oxalate API Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Escitalopram Oxalate API Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Escitalopram Oxalate API, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Escitalopram Oxalate API, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Escitalopram Oxalate API, Product Types and Applications
2.7 Global Key Manufacturers of Escitalopram Oxalate API, Date of Entry into the Industry
2.8 Global Escitalopram Oxalate API Market Competitive Situation and Trends
2.8.1 Global Escitalopram Oxalate API Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Escitalopram Oxalate API Players Market Share by Revenue
2.8.3 Global Escitalopram Oxalate API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Escitalopram Oxalate API Market Scenario by Region
3.1 Global Escitalopram Oxalate API Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Escitalopram Oxalate API Sales by Region: 2021–2032
3.2.1 Global Escitalopram Oxalate API Sales by Region: 2021–2026
3.2.2 Global Escitalopram Oxalate API Sales by Region: 2027–2032
3.3 Global Escitalopram Oxalate API Revenue by Region: 2021–2032
3.3.1 Global Escitalopram Oxalate API Revenue by Region: 2021–2026
3.3.2 Global Escitalopram Oxalate API Revenue by Region: 2027–2032
3.4 North America Escitalopram Oxalate API Market Facts & Figures by Country
3.4.1 North America Escitalopram Oxalate API Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Escitalopram Oxalate API Sales by Country (2021–2032)
3.4.3 North America Escitalopram Oxalate API Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Escitalopram Oxalate API Market Facts & Figures by Country
3.5.1 Europe Escitalopram Oxalate API Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Escitalopram Oxalate API Sales by Country (2021–2032)
3.5.3 Europe Escitalopram Oxalate API Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Escitalopram Oxalate API Market Facts & Figures by Region
3.6.1 Asia Pacific Escitalopram Oxalate API Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Escitalopram Oxalate API Sales by Region (2021–2032)
3.6.3 Asia Pacific Escitalopram Oxalate API Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Escitalopram Oxalate API Market Facts & Figures by Country
3.7.1 Latin America Escitalopram Oxalate API Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Escitalopram Oxalate API Sales by Country (2021–2032)
3.7.3 Latin America Escitalopram Oxalate API Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Escitalopram Oxalate API Market Facts & Figures by Country
3.8.1 Middle East and Africa Escitalopram Oxalate API Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Escitalopram Oxalate API Sales by Country (2021–2032)
3.8.3 Middle East and Africa Escitalopram Oxalate API Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Escitalopram Oxalate API Sales by Type (2021–2032)
4.1.1 Global Escitalopram Oxalate API Sales by Type (2021–2026)
4.1.2 Global Escitalopram Oxalate API Sales by Type (2027–2032)
4.1.3 Global Escitalopram Oxalate API Sales Market Share by Type (2021–2032)
4.2 Global Escitalopram Oxalate API Revenue by Type (2021–2032)
4.2.1 Global Escitalopram Oxalate API Revenue by Type (2021–2026)
4.2.2 Global Escitalopram Oxalate API Revenue by Type (2027–2032)
4.2.3 Global Escitalopram Oxalate API Revenue Market Share by Type (2021–2032)
4.3 Global Escitalopram Oxalate API Price by Type (2021–2032)
5 Segment by Application
5.1 Global Escitalopram Oxalate API Sales by Application (2021–2032)
5.1.1 Global Escitalopram Oxalate API Sales by Application (2021–2026)
5.1.2 Global Escitalopram Oxalate API Sales by Application (2027–2032)
5.1.3 Global Escitalopram Oxalate API Sales Market Share by Application (2021–2032)
5.2 Global Escitalopram Oxalate API Revenue by Application (2021–2032)
5.2.1 Global Escitalopram Oxalate API Revenue by Application (2021–2026)
5.2.2 Global Escitalopram Oxalate API Revenue by Application (2027–2032)
5.2.3 Global Escitalopram Oxalate API Revenue Market Share by Application (2021–2032)
5.3 Global Escitalopram Oxalate API Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sichuan Kelun
6.1.1 Sichuan Kelun Company Information
6.1.2 Sichuan Kelun Description and Business Overview
6.1.3 Sichuan Kelun Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sichuan Kelun Escitalopram Oxalate API Product Portfolio
6.1.5 Sichuan Kelun Recent Developments/Updates
6.2 Zhejiang Huahai
6.2.1 Zhejiang Huahai Company Information
6.2.2 Zhejiang Huahai Description and Business Overview
6.2.3 Zhejiang Huahai Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Zhejiang Huahai Escitalopram Oxalate API Product Portfolio
6.2.5 Zhejiang Huahai Recent Developments/Updates
6.3 Haisen Pharma
6.3.1 Haisen Pharma Company Information
6.3.2 Haisen Pharma Description and Business Overview
6.3.3 Haisen Pharma Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Haisen Pharma Escitalopram Oxalate API Product Portfolio
6.3.5 Haisen Pharma Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Viatris Escitalopram Oxalate API Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Cipla Escitalopram Oxalate API Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Aurobindo
6.6.1 Aurobindo Company Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aurobindo Escitalopram Oxalate API Product Portfolio
6.6.5 Aurobindo Recent Developments/Updates
6.7 Hetero Labs
6.7.1 Hetero Labs Company Information
6.7.2 Hetero Labs Description and Business Overview
6.7.3 Hetero Labs Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hetero Labs Escitalopram Oxalate API Product Portfolio
6.7.5 Hetero Labs Recent Developments/Updates
6.8 Neuland
6.8.1 Neuland Company Information
6.8.2 Neuland Description and Business Overview
6.8.3 Neuland Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Neuland Escitalopram Oxalate API Product Portfolio
6.8.5 Neuland Recent Developments/Updates
6.9 Smilax Laboratories
6.9.1 Smilax Laboratories Company Information
6.9.2 Smilax Laboratories Description and Business Overview
6.9.3 Smilax Laboratories Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Smilax Laboratories Escitalopram Oxalate API Product Portfolio
6.9.5 Smilax Laboratories Recent Developments/Updates
6.10 Jubilant Generics
6.10.1 Jubilant Generics Company Information
6.10.2 Jubilant Generics Description and Business Overview
6.10.3 Jubilant Generics Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jubilant Generics Escitalopram Oxalate API Product Portfolio
6.10.5 Jubilant Generics Recent Developments/Updates
6.11 Cadila Pharmaceuticals
6.11.1 Cadila Pharmaceuticals Company Information
6.11.2 Cadila Pharmaceuticals Description and Business Overview
6.11.3 Cadila Pharmaceuticals Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Cadila Pharmaceuticals Escitalopram Oxalate API Product Portfolio
6.11.5 Cadila Pharmaceuticals Recent Developments/Updates
6.12 Natco Pharma
6.12.1 Natco Pharma Company Information
6.12.2 Natco Pharma Description and Business Overview
6.12.3 Natco Pharma Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Natco Pharma Escitalopram Oxalate API Product Portfolio
6.12.5 Natco Pharma Recent Developments/Updates
6.13 Shodhana Laboratories
6.13.1 Shodhana Laboratories Company Information
6.13.2 Shodhana Laboratories Description and Business Overview
6.13.3 Shodhana Laboratories Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shodhana Laboratories Escitalopram Oxalate API Product Portfolio
6.13.5 Shodhana Laboratories Recent Developments/Updates
6.14 Dr. Reddy's
6.14.1 Dr. Reddy's Company Information
6.14.2 Dr. Reddy's Description and Business Overview
6.14.3 Dr. Reddy's Escitalopram Oxalate API Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Dr. Reddy's Escitalopram Oxalate API Product Portfolio
6.14.5 Dr. Reddy's Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Escitalopram Oxalate API Industry Chain Analysis
7.2 Escitalopram Oxalate API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Escitalopram Oxalate API Production Mode & Process Analysis
7.4 Escitalopram Oxalate API Sales and Marketing
7.4.1 Escitalopram Oxalate API Sales Channels
7.4.2 Escitalopram Oxalate API Distributors
7.5 Escitalopram Oxalate API Customer Analysis
8 Escitalopram Oxalate API Market Dynamics
8.1 Escitalopram Oxalate API Industry Trends
8.2 Escitalopram Oxalate API Market Drivers
8.3 Escitalopram Oxalate API Market Challenges
8.4 Escitalopram Oxalate API Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Escitalopram Oxalate API Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Escitalopram Oxalate API Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Escitalopram Oxalate API Market Competitive Situation by Manufacturers in 2025
Table 4. Global Escitalopram Oxalate API Sales (MT) of Key Manufacturers (2021–2026)
Table 5. Global Escitalopram Oxalate API Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Escitalopram Oxalate API Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Escitalopram Oxalate API Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Escitalopram Oxalate API Average Price (US$/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Escitalopram Oxalate API, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Escitalopram Oxalate API, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Escitalopram Oxalate API, Product Types and Applications
Table 12. Global Key Manufacturers of Escitalopram Oxalate API, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Escitalopram Oxalate API Companies by Tier (Tier 1, Tier 2, Tier 3), based on Escitalopram Oxalate API Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Escitalopram Oxalate API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Escitalopram Oxalate API Sales by Region (MT), 2021–2026
Table 18. Global Escitalopram Oxalate API Sales Market Share by Region (2021–2026)
Table 19. Global Escitalopram Oxalate API Sales by Region (MT), 2027–2032
Table 20. Global Escitalopram Oxalate API Sales Market Share by Region (2027–2032)
Table 21. Global Escitalopram Oxalate API Revenue by Region (US$ Million), 2021–2026
Table 22. Global Escitalopram Oxalate API Revenue Market Share by Region (2021–2026)
Table 23. Global Escitalopram Oxalate API Revenue by Region (US$ Million), 2027–2032
Table 24. Global Escitalopram Oxalate API Revenue Market Share by Region (2027–2032)
Table 25. North America Escitalopram Oxalate API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Escitalopram Oxalate API Sales by Country (MT), 2021–2026
Table 27. North America Escitalopram Oxalate API Sales by Country (MT), 2027–2032
Table 28. North America Escitalopram Oxalate API Revenue by Country (US$ Million), 2021–2026
Table 29. North America Escitalopram Oxalate API Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Escitalopram Oxalate API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Escitalopram Oxalate API Sales by Country (MT), 2021–2026
Table 32. Europe Escitalopram Oxalate API Sales by Country (MT), 2027–2032
Table 33. Europe Escitalopram Oxalate API Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Escitalopram Oxalate API Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Escitalopram Oxalate API Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Escitalopram Oxalate API Sales by Region (MT), 2021–2026
Table 37. Asia Pacific Escitalopram Oxalate API Sales by Region (MT), 2027–2032
Table 38. Asia Pacific Escitalopram Oxalate API Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Escitalopram Oxalate API Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Escitalopram Oxalate API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Escitalopram Oxalate API Sales by Country (MT), 2021–2026
Table 42. Latin America Escitalopram Oxalate API Sales by Country (MT), 2027–2032
Table 43. Latin America Escitalopram Oxalate API Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Escitalopram Oxalate API Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Escitalopram Oxalate API Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Escitalopram Oxalate API Sales by Country (MT), 2021–2026
Table 47. Middle East and Africa Escitalopram Oxalate API Sales by Country (MT), 2027–2032
Table 48. Middle East and Africa Escitalopram Oxalate API Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Escitalopram Oxalate API Revenue by Country (US$ Million), 2027–2032
Table 50. Global Escitalopram Oxalate API Sales (MT) by Type (2021–2026)
Table 51. Global Escitalopram Oxalate API Sales (MT) by Type (2027–2032)
Table 52. Global Escitalopram Oxalate API Sales Market Share by Type (2021–2026)
Table 53. Global Escitalopram Oxalate API Sales Market Share by Type (2027–2032)
Table 54. Global Escitalopram Oxalate API Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Escitalopram Oxalate API Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Escitalopram Oxalate API Revenue Market Share by Type (2021–2026)
Table 57. Global Escitalopram Oxalate API Revenue Market Share by Type (2027–2032)
Table 58. Global Escitalopram Oxalate API Price (US$/Kg) by Type (2021–2026)
Table 59. Global Escitalopram Oxalate API Price (US$/Kg) by Type (2027–2032)
Table 60. Global Escitalopram Oxalate API Sales (MT) by Application (2021–2026)
Table 61. Global Escitalopram Oxalate API Sales (MT) by Application (2027–2032)
Table 62. Global Escitalopram Oxalate API Sales Market Share by Application (2021–2026)
Table 63. Global Escitalopram Oxalate API Sales Market Share by Application (2027–2032)
Table 64. Global Escitalopram Oxalate API Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Escitalopram Oxalate API Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Escitalopram Oxalate API Revenue Market Share by Application (2021–2026)
Table 67. Global Escitalopram Oxalate API Revenue Market Share by Application (2027–2032)
Table 68. Global Escitalopram Oxalate API Price (US$/Kg) by Application (2021–2026)
Table 69. Global Escitalopram Oxalate API Price (US$/Kg) by Application (2027–2032)
Table 70. Sichuan Kelun Company Information
Table 71. Sichuan Kelun Description and Business Overview
Table 72. Sichuan Kelun Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 73. Sichuan Kelun Escitalopram Oxalate API Product
Table 74. Sichuan Kelun Recent Developments/Updates
Table 75. Zhejiang Huahai Company Information
Table 76. Zhejiang Huahai Description and Business Overview
Table 77. Zhejiang Huahai Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 78. Zhejiang Huahai Escitalopram Oxalate API Product
Table 79. Zhejiang Huahai Recent Developments/Updates
Table 80. Haisen Pharma Company Information
Table 81. Haisen Pharma Description and Business Overview
Table 82. Haisen Pharma Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 83. Haisen Pharma Escitalopram Oxalate API Product
Table 84. Haisen Pharma Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 88. Viatris Escitalopram Oxalate API Product
Table 89. Viatris Recent Developments/Updates
Table 90. Cipla Company Information
Table 91. Cipla Description and Business Overview
Table 92. Cipla Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 93. Cipla Escitalopram Oxalate API Product
Table 94. Cipla Recent Developments/Updates
Table 95. Aurobindo Company Information
Table 96. Aurobindo Description and Business Overview
Table 97. Aurobindo Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 98. Aurobindo Escitalopram Oxalate API Product
Table 99. Aurobindo Recent Developments/Updates
Table 100. Hetero Labs Company Information
Table 101. Hetero Labs Description and Business Overview
Table 102. Hetero Labs Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 103. Hetero Labs Escitalopram Oxalate API Product
Table 104. Hetero Labs Recent Developments/Updates
Table 105. Neuland Company Information
Table 106. Neuland Description and Business Overview
Table 107. Neuland Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 108. Neuland Escitalopram Oxalate API Product
Table 109. Neuland Recent Developments/Updates
Table 110. Smilax Laboratories Company Information
Table 111. Smilax Laboratories Description and Business Overview
Table 112. Smilax Laboratories Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 113. Smilax Laboratories Escitalopram Oxalate API Product
Table 114. Smilax Laboratories Recent Developments/Updates
Table 115. Jubilant Generics Company Information
Table 116. Jubilant Generics Description and Business Overview
Table 117. Jubilant Generics Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 118. Jubilant Generics Escitalopram Oxalate API Product
Table 119. Jubilant Generics Recent Developments/Updates
Table 120. Cadila Pharmaceuticals Company Information
Table 121. Cadila Pharmaceuticals Description and Business Overview
Table 122. Cadila Pharmaceuticals Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 123. Cadila Pharmaceuticals Escitalopram Oxalate API Product
Table 124. Cadila Pharmaceuticals Recent Developments/Updates
Table 125. Natco Pharma Company Information
Table 126. Natco Pharma Description and Business Overview
Table 127. Natco Pharma Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 128. Natco Pharma Escitalopram Oxalate API Product
Table 129. Natco Pharma Recent Developments/Updates
Table 130. Shodhana Laboratories Company Information
Table 131. Shodhana Laboratories Description and Business Overview
Table 132. Shodhana Laboratories Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 133. Shodhana Laboratories Escitalopram Oxalate API Product
Table 134. Shodhana Laboratories Recent Developments/Updates
Table 135. Dr. Reddy's Company Information
Table 136. Dr. Reddy's Description and Business Overview
Table 137. Dr. Reddy's Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 138. Dr. Reddy's Escitalopram Oxalate API Product
Table 139. Dr. Reddy's Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Escitalopram Oxalate API Distributors List
Table 143. Escitalopram Oxalate API Customers List
Table 144. Escitalopram Oxalate API Market Trends
Table 145. Escitalopram Oxalate API Market Drivers
Table 146. Escitalopram Oxalate API Market Challenges
Table 147. Escitalopram Oxalate API Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Escitalopram Oxalate API
Figure 2. Global Escitalopram Oxalate API Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Escitalopram Oxalate API Market Share by Type: 2025 & 2032
Figure 4. Both USDMF and COS/E-DM Product Picture
Figure 5. Only USDMF or COS/E-DM Product Picture
Figure 6. Global Escitalopram Oxalate API Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Escitalopram Oxalate API Market Share by Application: 2025 & 2032
Figure 8. Depression Drug
Figure 9. Anxiety Drug
Figure 10. Global Escitalopram Oxalate API Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Escitalopram Oxalate API Market Size (US$ Million), 2021–2032
Figure 12. Global Escitalopram Oxalate API Sales (MT), 2021–2032
Figure 13. Global Escitalopram Oxalate API Average Price (US$/Kg), 2021–2032
Figure 14. Escitalopram Oxalate API Report Years Considered
Figure 15. Escitalopram Oxalate API Sales Share by Manufacturers in 2025
Figure 16. Global Escitalopram Oxalate API Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Escitalopram Oxalate API Players: Market Share by Revenue in Escitalopram Oxalate API in 2025
Figure 18. Escitalopram Oxalate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Escitalopram Oxalate API Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Escitalopram Oxalate API Sales Market Share by Country (2021–2032)
Figure 21. North America Escitalopram Oxalate API Revenue Market Share by Country (2021–2032)
Figure 22. United States Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Escitalopram Oxalate API Sales Market Share by Country (2021–2032)
Figure 25. Europe Escitalopram Oxalate API Revenue Market Share by Country (2021–2032)
Figure 26. Germany Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Escitalopram Oxalate API Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Escitalopram Oxalate API Revenue Market Share by Region (2021–2032)
Figure 33. China Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Escitalopram Oxalate API Sales Market Share by Country (2021–2032)
Figure 41. Latin America Escitalopram Oxalate API Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Middle East and Africa Escitalopram Oxalate API Sales Market Share by Country (2021–2032)
Figure 46. Middle East and Africa Escitalopram Oxalate API Revenue Market Share by Country (2021–2032)
Figure 47. Turkey Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Saudi Arabia Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. UAE Escitalopram Oxalate API Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Global Sales Market Share of Escitalopram Oxalate API by Type (2021–2032)
Figure 51. Global Revenue Market Share of Escitalopram Oxalate API by Type (2021–2032)
Figure 52. Global Escitalopram Oxalate API Price (US$/Kg) by Type (2021–2032)
Figure 53. Global Sales Market Share of Escitalopram Oxalate API by Application (2021–2032)
Figure 54. Global Revenue Market Share of Escitalopram Oxalate API by Application (2021–2032)
Figure 55. Global Escitalopram Oxalate API Price (US$/Kg) by Application (2021–2032)
Figure 56. Escitalopram Oxalate API Value Chain
Figure 57. Channels of Distribution (Direct Vs Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
